Skip to main content
Clinical Trials/DRKS00004525
DRKS00004525
Recruiting
Phase 2

Efficacy of Mindfulness Based Cognitive Therapy for patients with Obsessive Compulsive Disorder

niversitätsklinik für Psychiatrie und PsychosomatikAbteilung Psychiatrie und Psychotherapie0 sites128 target enrollmentMarch 19, 2013

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
F42
Sponsor
niversitätsklinik für Psychiatrie und PsychosomatikAbteilung Psychiatrie und Psychotherapie
Enrollment
128
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 19, 2013
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinik für Psychiatrie und PsychosomatikAbteilung Psychiatrie und Psychotherapie

Eligibility Criteria

Inclusion Criteria

  • written informed consent
  • primary diagnosis of OCD (ICD\-10 F42\.\-)
  • at least 20 sessions of CBT with ERP within 3 years prior to study
  • clinically relevant OCD, i.e. Y\-BOCS global score \> 12 at study
  • fulfilled DSM\-IV criteria for OCD for a period of \= three years prior to
  • study inclusion, either without an aymptomatic period or an
  • asymptomatic period of \< 6 months

Exclusion Criteria

  • begun or altered medication within 12 weeks before study inclusion
  • receiving benzodiazepines
  • mania (ICD\-10 F30\.\-)
  • suicidal tendency
  • current severe depressive episode (BDI\>28\)
  • borderline disorder (ICD\-10 F60\.3\)
  • current substance abuse or substance dependence (ICD\-10 F1x.2\)
  • intelligence quotient \< 70
  • psychosis (ICD\-10 F20\-F29\)
  • severe neurological disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials